These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A novel vaccine candidate based on chimeric virus-like particle displaying multiple conserved epitope peptides induced neutralizing antibodies against EBV infection. Zhang X; Zhao B; Ding M; Song S; Kang Y; Yu Y; Xu M; Xiang T; Gao L; Feng Q; Zhao Q; Zeng MS; Krummenacher C; Zeng YX Theranostics; 2020; 10(13):5704-5718. PubMed ID: 32483413 [No Abstract] [Full Text] [Related]
6. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles. Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749 [TBL] [Abstract][Full Text] [Related]
7. Virus like particles as a platform for cancer vaccine development. Ong HK; Tan WS; Ho KL PeerJ; 2017; 5():e4053. PubMed ID: 29158984 [TBL] [Abstract][Full Text] [Related]
11. Modification of Asparagine-Linked Glycan Density for the Design of Hepatitis B Virus Virus-Like Particles with Enhanced Immunogenicity. Hyakumura M; Walsh R; Thaysen-Andersen M; Kingston NJ; La M; Lu L; Lovrecz G; Packer NH; Locarnini S; Netter HJ J Virol; 2015 Nov; 89(22):11312-22. PubMed ID: 26339047 [TBL] [Abstract][Full Text] [Related]
12. Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity. Joe CCD; Chatterjee S; Lovrecz G; Adams TE; Thaysen-Andersen M; Walsh R; Locarnini SA; Smooker P; Netter HJ Vaccine; 2020 May; 38(22):3892-3901. PubMed ID: 32284273 [TBL] [Abstract][Full Text] [Related]
13. Construction of polyomavirus-derived pseudotype virus-like particles displaying a functionally active neutralizing antibody against hepatitis B virus surface antigen. Pleckaityte M; Bremer CM; Gedvilaite A; Kucinskaite-Kodze I; Glebe D; Zvirbliene A BMC Biotechnol; 2015 Sep; 15():85. PubMed ID: 26370129 [TBL] [Abstract][Full Text] [Related]
14. Chimeric HBcAg virus-like particles presenting a HPV 16 E7 epitope significantly suppressed tumor progression through preventive or therapeutic immunization in a TC-1-grafted mouse model. Chu X; Li Y; Long Q; Xia Y; Yao Y; Sun W; Huang W; Yang X; Liu C; Ma Y Int J Nanomedicine; 2016; 11():2417-29. PubMed ID: 27313455 [TBL] [Abstract][Full Text] [Related]
15. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies. Vietheer PT; Boo I; Drummer HE; Netter HJ Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556 [TBL] [Abstract][Full Text] [Related]
16. Chimeric Virus-Like Particles of Prawn Nodavirus Displaying Hepatitis B Virus Immunodominant Region: Biophysical Properties and Cytokine Response. Ninyio NN; Ho KL; Yong CY; Chee HY; Hamid M; Ong HK; Mariatulqabtiah AR; Tan WS Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672018 [TBL] [Abstract][Full Text] [Related]
17. Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs. Zepeda-Cervantes J; Ramírez-Jarquín JO; Vaca L Front Immunol; 2020; 11():1100. PubMed ID: 32582186 [TBL] [Abstract][Full Text] [Related]
18. Current status and future directions of fish vaccines employing virus-like particles. Jeong KH; Kim HJ; Kim HJ Fish Shellfish Immunol; 2020 May; 100():49-57. PubMed ID: 32130976 [TBL] [Abstract][Full Text] [Related]
19. Disassembly and reassembly of human papillomavirus virus-like particles produces more virion-like antibody reactivity. Zhao Q; Modis Y; High K; Towne V; Meng Y; Wang Y; Alexandroff J; Brown M; Carragher B; Potter CS; Abraham D; Wohlpart D; Kosinski M; Washabaugh MW; Sitrin RD Virol J; 2012 Feb; 9():52. PubMed ID: 22356831 [TBL] [Abstract][Full Text] [Related]